FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Ascend Laboratories Atorvastatin Calcium Tablet 80 mg Recall

Atorvastatin Calcium Tablet USP 80 mg, a) 90 count (NDC 67877-0514-90) and b) 500 count…

Ascend Laboratories LLC · Parsippany, NJ

Risk level
Class II
Reported by FDA
Jul 31, 2019
Recall ID
D-1515-2019
Check your lot numberHow we source this data

Summary

Ascend Laboratories recalled Atorvastatin Calcium Tablet 80 mg starting Jul 19, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1515-2019 on Jul 31, 2019. Reason: Failed Dissolution Specifications. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications

Product description

Atorvastatin Calcium Tablet USP 80 mg, a) 90 count (NDC 67877-0514-90) and b) 500 count (NDC 67877-0514-05) bottles, Rx only, Manufactured by: Alkem Laboratories, Ltd, Mumbai INDIA, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ

Lot numbers, UPCs & expiration codes

a) Lot# 19140443, exp. date 12/2020, Lot# 19140525, 19140535, exp. date 01/2021 and b) Lot# 19140756, exp. date 12/2020, Lot# 19140757, Lot# 19140758, exp. date 01/2021, Lot# 19141696, Lot# 19141793, exp. date 03/2021

Where it was sold

Product was shipped to wholesalers throughout the United States.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1515-2019
Classification
Class II
Status
Terminated
Recall initiated
Jul 19, 2019
FDA report date
Jul 31, 2019
Quantity
a) 5,472 bottles and b) 5,880 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Ascend Laboratories LLC

Original FDA data

Every field from FDA enforcement report D-1515-2019, exactly as published.

Show all FDA fields
City
Parsippany
State
NJ
Status
Terminated
Country
United States
Event ID
83378
Address
339 Jefferson Rd Ste 101
Code information
a) Lot# 19140443, exp. date 12/2020, Lot# 19140525, 19140535, exp. date 01/2021 and b) Lot# 19140756, exp. date 12/2020, Lot# 19140757, Lot# 19140758, exp. date 01/2021, Lot# 19141696, Lot# 19141793, exp. date 03/2021
Postal code
07054-3707
Report date
Jul 31, 2019
Product type
Drugs
Recall number
D-1515-2019
Classification
Class II
Recalling firm
Ascend Laboratories LLC
Product quantity
a) 5,472 bottles and b) 5,880 bottles
Termination date
Jun 7, 2021
Reason for recall
Failed Dissolution Specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
Atorvastatin Calcium Tablet USP 80 mg, a) 90 count (NDC 67877-0514-90) and b) 500 count (NDC 67877-0514-05) bottles, Rx only, Manufactured by: Alkem Laboratories, Ltd, Mumbai INDIA, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ
Distribution pattern
Product was shipped to wholesalers throughout the United States.
Recall initiation date
Jul 19, 2019
Initial firm notification
Letter
Center classification date
Jul 24, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1515-2019, published Jul 31, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls